MSPRX
Price
$23.13
Change
-$0.12 (-0.52%)
Updated
Jun 5 closing price
Net Assets
214.3M
RGEBX
Price
$75.21
Change
+$0.72 (+0.97%)
Updated
Jun 6 closing price
Net Assets
304.87B
Interact to see
Advertisement

MSPRX vs RGEBX

Header iconMSPRX vs RGEBX Comparison
Open Charts MSPRX vs RGEBXBanner chart's image
Morgan Stanley Inst Advantage C
Price$23.13
Change-$0.12 (-0.52%)
VolumeN/A
Net Assets214.3M
American Funds Growth Fund of Amer R2E
Price$75.21
Change+$0.72 (+0.97%)
VolumeN/A
Net Assets304.87B
MSPRX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MSPRX vs. RGEBX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSPRX is a Buy and RGEBX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 305B vs. MSPRX (214M). MSPRX pays higher dividends than RGEBX: MSPRX (0.57) vs RGEBX (0.00). MSPRX was incepted earlier than RGEBX: MSPRX (10 years) vs RGEBX (11 years). MSPRX (2.04) is less costly to investors than RGEBX (1.09). MSPRX is a more actively managed with annual turnover of: 57.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than MSPRX: RGEBX (250) vs MSPRX (1000). MSPRX annual gain was more profitable for investors over the last year : 54.30 vs. RGEBX (8.53). RGEBX return over 5 years is better than : 41.54 vs. MSPRX (-22.80).
MSPRXRGEBXMSPRX / RGEBX
Total Expense Ratio1.951.09179%
Annual Report Gross Expense Ratio2.041.09187%
Fund Existence10 years11 years-
Gain YTD13.6925.277259%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets214M305B0%
Annual Yield % from dividends0.570.00-
Returns for 1 year54.308.53637%
Returns for 3 years47.8635.32136%
Returns for 5 years-22.8041.54-55%
Returns for 10 years30.9767.9946%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCTX3.350.06
+1.82%
Briacell Therapeutics Corp NEW
GVA90.660.95
+1.06%
Granite Construction
MLYS15.610.09
+0.58%
Mineralys Therapeutics
THRD5.280.01
+0.09%
Third Harmonic Bio
MBLY16.50-0.29
-1.70%
Mobileye Global